108660 Hertz, Sharon Avigan, Mark Recommendation on a Regulatory Decision for Propoxyphene-containing Products FDA Center for Drug Evaluation and Research. Memorandum to the File NDA 10-997 Darvon (propoxyphene hydrochloride) Capsules NDA 16-862 Darvon-N (propoxyphene napsylate and acetaminophen) Tablets NDA 17-122 Darvocet-N 50 and Darvocet-N 100 (propoxyphene napsylate and acetaminophen) Tablets 2865911 2010 Nov 18, 2010 Washington, DC United States Department of Health and Human Services http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM234349.pdf